Innovent Biologics, Inc. (IVBXF)
12.20
0.00 (0.00%)
USD |
OTCM |
Oct 06, 16:00
Innovent Biologics Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 06, 2026 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Ascletis Pharma, Inc. | 9.360 |
| CStone Pharmaceuticals Co. Ltd. | 9.788 |
| RemeGen Co., Ltd. | 4.559 |
| InnoCare Pharma Ltd. | 2.888 |
| Adagene, Inc. | -- |
Price to Book Value Related Metrics
| PE Ratio | 122.37 |
| PS Ratio | 9.583 |
| Price to Free Cash Flow | 11.76 |
| Price | 12.20 |
| Earnings Yield | 0.82% |
| Market Cap | 21.21B |
| Operating PE Ratio | 56.73 |
| Normalized PE Ratio | 138.95 |